- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 29.10. | Stenocare A/S: STENOCARE reports 53% revenue growth in Q3-2026 and maintains full-year ambition for positive EBITDA | 131 | GlobeNewswire (Europe) | STENOCARE A/S
NASDAQ FIRST NORTH GROWTH MARKET, DENMARK
TICKER: STENO
STENOCARE A/S ("STENOCARE") today announces its results for the period 01.01.2026 - 30.09.2026. The report, which has not been... ► Artikel lesen | |
| 02.10. | Stenocare A/S: STENOCARE provides update on future supply of Bedrocan medical cannabis products | 212 | GlobeNewswire (Europe) | STENOCARE A/S
NASDAQ FIRST NORTH GROWTH MARKET, DENMARK
TICKER: STENO
This information is information that STENOCARE A/S is obliged to publish in accordance with the EU Market Abuse Regulation. The... ► Artikel lesen | |
| 21.09. | STENOCARE A/S: Danish Medicines Agency publishes annual medical cannabis safety report - no new safety signals identified | 1 | Cision News | ||
| 07.09. | Stenocare A/S: Germany's DKK 8.5 billion medical cannabis market in continued uncertainty over the new reimbursement rules | 388 | GlobeNewswire (Europe) | STENOCARE A/S
NASDAQ FIRST NORTH GROWTH MARKET, DENMARK
TICKER: STENOWith this market update, STENOCARE A/S aims to provide its current understanding of the latest developments in the German medical... ► Artikel lesen | |
| 20.08. | Stenocare A/S: STENOCARE reports first-half results with continued momentum: Q2 sales rise 33% over Q1 with fifth consecutive EBITDA-positive quarter | 212 | GlobeNewswire (Europe) | STENOCARE A/S
NASDAQ FIRST NORTH GROWTH MARKET, DENMARK
TICKER: STENO
STENOCARE A/S ("STENOCARE") today announces its results for the period 01.01.2026 - 30.06.2026. The report, which has not been... ► Artikel lesen | |
| 07.08. | Stenocare A/S: France reaches important milestone towards permanent legalisation of medical cannabis | 196 | GlobeNewswire (Europe) | STENOCARE A/S
NASDAQ FIRST NORTH GROWTH MARKET, DENMARK
TICKER: STENO
STENOCARE A/S (STENOCARE) provides an update on the regulatory development of the French medical cannabis programme. The long-awaited... ► Artikel lesen | |
| 03.07. | Stenocare A/S: STENOCARE completes integration of CannGros ApS | 259 | GlobeNewswire (Europe) | STENOCARE A/S
NASDAQ FIRST NORTH GROWTH MARKET, DENMARK
TICKER: STENO
STENOCARE A/S ("STENOCARE") is pleased to announce that the integration of CannGros ApS, acquired in November 2025, has now been... ► Artikel lesen | |
| 07.05. | Stenocare A/S: Interim report first quarter 2026 | 396 | GlobeNewswire (Europe) | STENOCARE A/S
NASDAQ FIRST NORTH GROWTH MARKET, DENMARK
TICKER: STENOSTENOCARE A/S ("STENOCARE") today announces its results for the period 01.01.2026 - 31.03.2026. The report, which has not been reviewed... ► Artikel lesen | |
| STENOCARE Aktie jetzt für 0€ handeln | |||||
| 29.04. | Stenocare A/S: Communiqué from Annual General Meeting | 236 | GlobeNewswire (Europe) | STENOCARE A/S
NASDAQ FIRST NORTH GROWTH MARET, DENMARK
TICKER: STENO
On 29 April 2026 annual general meeting of shareholders of STENOCARE A/S, CVR no. 39024705, was held at Lund Elmer Sandager Law... ► Artikel lesen | |
| 26.02. | Stenocare A/S: Interim report fourth quarter and Financial Statement Release 2025 | 258 | GlobeNewswire (Europe) | STENOCARE A/S
NASDAQ FIRST NORTH GROWTH MARKET, DENMARK
TICKER: STENO
STENOCARE A/S ("STENOCARE") today announces its results for the period 01.01.2025 - 31.12.2025. The report, which has not been... ► Artikel lesen | |
| 11.02. | Stenocare A/S: STENOCARE A/S positions for First-Mover Advantage in France With Strategic Partnership, Product Filing, and National Distribution Partnership | 262 | GlobeNewswire (Europe) | STENOCARE A/S
NASDAQ FIRST NORTH GROWTH MARKET, DENMARK
TICKER: STENO
STENOCARE A/S ("STENOCARE") has entered a strategic partnership with Institut des Cannabinoïdes Médicaux Français (="ICMF") to... ► Artikel lesen | |
| 27.01. | Stenocare A/S: Stenocare Kicks Off Strategic Partnership with WEECO to Launch New Astrum Oil Product in Germany | 541 | GlobeNewswire (Europe) | STENOCARE A/S
NASDAQ FIRST NORTH GROWTH MARKET, DENMARK
TICKER: STENO
Stenocare Enters Strategic Partnership with WEECO Pharma GmbH to Launch Premium Medical Cannabis Oils in Germany. The first new... ► Artikel lesen | |
| 17.11.25 | Stenocare A/S: STENOCARE A/S acquires CannGros ApS and add DKK 4-6 million in annual revenue and supports 2026 break even goal | 306 | GlobeNewswire (Europe) | STENOCARE A/S
NASDAQ FIRST NORTH GROWTH MARKET, DENMARK
TICKER: STENO
This information is information that STENOCARE A/S is obliged to publish in accordance with the EU Market Abuse Regulation. The... ► Artikel lesen |
13 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| AURORA CANNABIS | 4,550 | -0,31 % | Aurora Cannabis: Deal-Freigaben da - was jetzt noch fehlt | ||
| ABBVIE | 262,20 | -0,42 % | Eli Lilly kauft AtaiBeckley für 2,8 Milliarden Dollar - wer behandelt künftig die Patienten? | ||
| CANOPY GROWTH | 0,539 | +1,32 % | Ihre wichtigsten Termine: Spannende Updates von: Moderna, Krones, Daimler Truck, Under Armour & Brookfield | © Foto: Bodo Schackow/dpaGut geplant in den Tag. Mit dem wO-Tagesausblick haben Sie die wichtigsten Termine im Blick und starten bestens vorbereitet in den neuen Handelstag Enthaltene Werte: CA29250N1050... ► Artikel lesen | |
| TILRAY BRANDS | 2,275 | -4,41 % | Tilray Brands, Inc.: 10 Barrel Brewing, Widmer Brothers and Hop Valley Named Official Craft Beer Partners of the Portland Trail Blazers | ||
| INNOCAN PHARMA | 1,045 | -1,42 % | Innocan Pharma: Erste Tranche zu - was jetzt wichtig wird | ||
| TAAT GLOBAL ALTERNATIVES | 0,136 | -100,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 02.10.2026 -2- | The following instruments on Boerse Frankfurt do have their last trading day on 02.10.2026Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 02.10.2026ISIN NameCA83013Q8719 CORE... ► Artikel lesen | |
| DERMAPHARM | 38,875 | +0,97 % | EQS-AFR: Dermapharm Holding SE: Vorabbekanntmachung über die Veröffentlichung von Quartalsberichten und Quartals-/Zwischenmitteilungen | EQS Vorabbekanntmachung Finanzberichte: Dermapharm Holding SE
/ Vorabbekanntmachung über die Veröffentlichung von Rechnungslegungsberichten
Dermapharm Holding SE: Vorabbekanntmachung... ► Artikel lesen | |
| CRONOS GROUP | 3,038 | -0,72 % | Cronos Group Q3 2026 Earnings Call Transcript | ||
| SYNBIOTIC | 0,113 | -2,41 % | SYNBIOTIC SE: Zuvor aufgezeigte Risiken haben sich materialisiert; Rating und Kursziel under review | SYNBIOTIC hat angekündigt, einen Insolvenzantrag zu stellen, nachdem es dem Unternehmen angesichts anhaltend schwieriger Marktbedingungen nicht gelungen ist, eine ausreichende Finanzierung sicherzustellen.... ► Artikel lesen | |
| DIGICANN VENTURES | 0,006 | 0,00 % | XFRA VY3: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILDIGICANN VENTURES... ► Artikel lesen | |
| ORGANIGRAM GLOBAL | 0,763 | -0,26 % | Organigram: Aurora Cannabis Acquisition Valued At C$561 Million To Create Global Cannabis Platform | ||
| GREEN THUMB INDUSTRIES | 5,930 | +0,17 % | Green Thumb Indus Q3 2026 Earnings Call Transcript | ||
| SNDL | 1,270 | +1,60 % | Immortal Dragons: Sundial Initiative Advisor Boyang Wang Sponsors Nakauchi Lab's Work on "Bodyoids" | SINGAPORE, SG / ACCESS Newswire / July 30, 2026 / Boyang Wang, advisor to the Sundial Initiative and founder and CEO of the longevity fund Immortal Dragons, has sponsored the Nakauchi Lab, led by stem... ► Artikel lesen | |
| CRESCO LABS | 0,463 | -5,99 % | Cresco Labs: Q3 Revenue Reaches $173 Million And Free Cash Flow Totals $21 Million | ||
| NOVERIS HEALTH SCIENCES | 0,025 | 0,00 % | Noveris Health Sciences Inc.: Noveris Health Sciences Announces Results of 2026 Annual General and Special Meeting | Vancouver, British Columbia--(Newsfile Corp. - September 9, 2026) - Noveris Health Sciences Inc. (CSE: NVRS) (FSE: 0NF1) (OTC Pink: MYCOF) (the "Company" or "Noveris") announces the results of its annual... ► Artikel lesen |
Das Unternehmen STENOCARE A/S kann der Branche Pharma zugeordnet werden. Die relative Kursveränderung beträgt aktuell -4,23 % bei einem Aktienkurs von 0,082 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu STENOCARE A/S finden Sie auf Wallstreet Online.